Cargando…
Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma
Multiple myeloma (MM) is the second most common hematological malignancy in adults. It is characterized by clonal proliferation of terminally differentiated B lymphocytes and over-production of monoclonal immunoglobulins. Recurrent genomic aberrations have been identified to contribute to the aggres...
Autores principales: | Micallef, Johann, Dharsee, Moyez, Chen, Jian, Ackloo, Suzanne, Evans, Ken, Qiu, Luqui, Chang, Hong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868782/ https://www.ncbi.nlm.nih.gov/pubmed/20374647 http://dx.doi.org/10.1186/1756-8722-3-13 |
Ejemplares similares
-
Applying mass spectrometry-based qualitative proteomics to human amygdaloid complex
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2014) -
Contributions of Mass Spectrometry-Based Proteomics to Understanding Salmonella-Host Interactions
por: Zhang, Buyu, et al.
Publicado: (2020) -
Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival
por: Cawthorn, Thomas R., et al.
Publicado: (2012) -
An automated proteomic data analysis workflow for mass spectrometry
por: Pendarvis, Ken, et al.
Publicado: (2009) -
Current Status and Advances in Quantitative Proteomic Mass Spectrometry
por: Wasinger, Valerie C., et al.
Publicado: (2013)